89281-44-7

Usage

Uses

Used in Pharmaceutical Industry:
5-Thiazolamine, 2-methylis used as a building block for the synthesis of various pharmaceuticals due to its diverse biological and pharmacological activities. It contributes to the development of new drugs and treatments, particularly those with antimicrobial and antifungal properties.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Thiazolamine, 2-methylis utilized as a key component in the synthesis of agrochemicals, leveraging its antimicrobial and antifungal properties to create effective solutions for agricultural applications.
Used in Dye Production:
5-Thiazolamine, 2-methylis used as an important intermediate in the production of dyes, contributing to the development of a wide range of colorants for various industries.
Used in Organic Compound Synthesis:
As a versatile chemical compound, 5-Thiazolamine, 2-methylis employed in the synthesis of other organic compounds, expanding its applications across different sectors.
Used in Antimicrobial and Antifungal Applications:
5-Thiazolamine, 2-methylis used as an antimicrobial and antifungal agent in the development of new treatments and drugs, thanks to its potent properties in inhibiting the growth of various microorganisms and fungi.

Upstream product

• 594-03-6 dithioacetic acid 
• 540-61-4 2-aminoacetonitrile 
• 870-73-5 ethyl dithioacetate 
• 151-63-3 cyanomethylamine sulfate 

Downstream Products

• 6449-69-0 2-Methyl-5-acetamino-thiazol 
• 1298094-96-8 tetraphenyl (2-methylthiazol-5-ylamino)methylenediphosphonate 

Relevant academic research and scientific papers

Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer

The bisamide class of kinase inhibitors was identified as being active against CSF-1R. The synthesis and SAR of pyridyl and thiazolyl bisamides are reported, along with the pharmacokinetic properties and in vivo activity of selected examples.

CHEMICAL COMPOUNDS

The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof of the formula which possess CSF 1R kinase inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.

Imidazopyrazines as protein kinase inhibitors

In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions.

Positive allosteric modulators of the nicotinic acetylcholine receptor

The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.